Table 3 Referrals for evaluation for obesity-related comorbidities, dietitian and endocrine counseling, prescriptions of anti-obesity medications and change in BMI-Z scores during a 1–2-year interval according to the presence of overweight or obesity and the recorded diagnosis of overweight or obesity.
From: Recorded diagnosis of overweight/obesity in primary care is linked to obesity care performance rates
Patients with overweight without a recorded diagnosis of overweight | Patients with overweight with a | Patients with obesity without a recorded diagnosis of obesity | Patients with obesity with a | P1 | |
---|---|---|---|---|---|
recorded diagnosis of overweight | recorded diagnosis of obesity | ||||
Age 2–5 years | |||||
Total | 9536 (34.2) | 11,600 (41.7) | 2158 (7.7) | 4556 (16.4) | |
Sex | |||||
males | 5121 (53.7)a | 5901 (50.9)b | 1254 (58.1)c | 2480 (54.4)d | <0.001 |
females | 4415 (46.3) | 5699 (49.1) | 904 (41.9) | 2076 (45.6) | |
Blood pressure measurement | |||||
males | 456 (8.9)a | 2011 (34.1)b | 131 (10.4)a | 1026 (41.4)c | <0.001 |
females | 332 (7.5)a | 1934 (33.9)b | 90 (10.0)c | 821 (39.5)d | <0.001 |
P2 | 0.016 | 0.889 | 0.765 | 0.223 | |
Referral to blood glucose measurement | |||||
males | 1632 (31.9)a | 2915 (49.4)b | 410 (32.7)a | 1512 (61.0)c | <0.001 |
females | 1337 (30.3)a | 3038 (53.3)b | 310 (34.3)c | 1318 (63.5)d | <0.001 |
P2 | 0.1 | <0.001 | 0.465 | 0.086 | |
Referral to HbA1C measurement | |||||
males | 198 (3.9)a | 1166 (19.8)b | 65 (5.2)c | 915 (36.9)d | <0.001 |
females | 198 (4.5)a | 1503 (26.4)b | 57 (6.3)c | 883 (42.5)d | <0.001 |
P2 | 0.145 | <0.001 | 0.308 | <0.001 | |
Referral to liver enzyme measurement | |||||
males | 1828 (35.7)a | 3144 (53.3)b | 456 (36.4)a | 1594 (64.3)c | <0.001 |
females | 1484 (33.6)a | 3228 (56.6)b | 332 (36.7)a | 1367 (65.8)c | <0.001 |
P2 | 0.035 | <0.001 | 0.899 | 0.281 | |
Referral to lipid profile measurement | |||||
males | 984 (19.2)a | 2151 (36.5)b | 261 (20.8)a | 1318 (53.1)c | <0.001 |
females | 849 (19.2)a | 2469 (43.3)b | 229 (25.3)c | 1179 (56.8)d | <0.001 |
P2 | 0.895 | <0.001 | 0.016 | 0.015 | |
Referral to liver ultrasound | |||||
males | 165 (3.2)a | 383 (6.5)b | 45 (3.6)a | 244 (9.8)c | <0.001 |
females | 174 (3.9)a | 553 (9.7)b | 40 (4.4)a | 274 (13.2)c | <0.001 |
P2 | 0.066 | <0.001 | 0.383 | <0.001 | |
Referral to sleep study | |||||
males | 52 (1.0)a | 90 (1.5)b | 17 (1.4)ab | 79 (3.2)c | <0.001 |
females | 34 (0.8)a | 64 (1.1)a | 6 (0.7)a | 56 (2.7)b | <0.001 |
P2 | 0.248 | 0.07 | 0.183 | 0.379 | |
Referral to a dietitian | |||||
males | 132 (2.6)a | 677 (11.5)b | 50 (4.0)c | 669 (27.0)d | <0.001 |
females | 140 (3.2)a | 1063 (18.7)b | 55 (6.1)c | 759 (36.6)d | <0.001 |
P2 | 0.094 | <0.001 | 0.033 | <0.001 | |
Referral to an endocrinologist | |||||
males | 191 (3.7)a | 350 (5.9)b | 30 (2.4)c | 282 (11.4)d | <0.001 |
females | 169 (3.8)a | 516 (9.1)b | 23 (2.5)c | 336 (16.2)d | <0.001 |
P2 | 0.844 | <0.001 | 0.933 | <0.001 | |
Additional BMI documentation | |||||
males | 3429 (67.0)a | 5081 (86.1)b | 716 (57.1)c | 2153 (86.8)d | <0.001 |
females | 2875 (65.1)a | 4969 (87.2)b | 497 (55.0)c | 1759 (84.7)d | <0.001 |
P2 | 0.061 | 0.091 | 0.35 | 0.049 | |
1–2 years change in BMI-Z | |||||
males | (n = 1478) −0.99 a (−1.66, −0.37) | (n = 2751) −0.38 b (−1.16, 0.38) | (n = 281) −1.59 c (-2.89, -0.56) | (n = 1161) −0.20 b (−1.02, 0.49) | <0.001 |
females | (n = 1194) −0.97 a (−1.62, −0.32) | (n = 2727) −0.30 b (−0.89, 0.30) | (n = 217) −1.32 c (−2.36, −0.44) | (n = 975) −0.32 b (−0.99, 0.24) | <0.001 |
P2 | 0.443 | 0.016 | 0.105 | 0.002 | |
Age >5-18 years | |||||
Total | 112,604 (32.9) | 117,102 (34.2) | 20,829 (6.1) | 92,244 (26.9) | |
Sex | |||||
males | 57,965 (51.5)a | 57,534 (49.1)b | 12,551 (60.3)c | 51,832 (56.2)d | <0.001 |
females | 54,639 (48.5) | 59,568 (50.9) | 8278 (39.7) | 40,412 (43.8) | |
Blood pressure measurement | |||||
males | 24,316 (41.9)a | 36,748 (63.9)b | 3552 (28.3)c | 34,578 (66.7)d | <0.001 |
females | 22,054 (40.4)a | 37,836 (63.5)b | 2131 (25.7)c | 26,882 (66.5)d | <0.001 |
P2 | <0.001 | 0.209 | <0.001 | 0.545 | |
Referral to blood glucose measurement | |||||
males | 27,699 (47.8)a | 37,300 (64.8)b | 5140 (41.0)c | 38,362 (73.9)d | <0.001 |
females | 31,316 (57.3)a | 44,383 (74.5)b | 3930 (47.5)c | 32,799 (81.2)d | <0.001 |
P2 | <0.001 | <0.001 | <0.001 | <0.001 | |
Referral to HbA1C measurement | |||||
males | 7793 (13.4)a | 19,536 (34.0)b | 1471 (11.7)c | 27,212 (52.5)d | <0.001 |
females | 9408 (17.2)a | 25,041 (42.0)b | 1233 (14.9)c | 24,079 (59.6)d | <0.001 |
P2 | <0.001 | <0.001 | <0.001 | <0.001 | |
Referral to liver enzyme measurement | |||||
males | 29,342 (50.6)a | 38,891 (67.6)b | 5478 (43.6)c | 3887 (75.0)d | <0.001 |
females | 32,748 (59.9)a | 45,658 (76.6)b | 4128 (49.9)c | 33,133 (82.0)d | <0.001 |
P2 | <0.001 | <0.001 | <0.001 | <0.001 | |
Referral to lipid profile measurement | |||||
males | 22,931 (39.6)a | 33,804 (58.8)b | 4268 (34.0)c | 36,625 (70.7)d | <0.001 |
females | 27,027 (49.5)a | 41,132 (69.1)b | 3382 (40.9)c | 31,806 (78.7)d | <0.001 |
P2 | <0.001 | <0.001 | <0.001 | <0.001 | |
Referral to liver ultrasound | |||||
males | 2513 (4.3)a | 4420 (7.7)b | 411 (3.3)c | 6545 (12.6)d | <0.001 |
females | 3633 (6.6)a | 7060 (11.9)b | 400 (4.8)c | 7268 (18.0)d | <0.001 |
P2 | <0.001 | <0.001 | <0.001 | <0.001 | |
Referral to sleep study | |||||
males | 146 (0.3)a | 283 (0.5)b | 37 (0.3)a | 404 (0.8)c | <0.001 |
females | 129 (0.2)a | 212 (0.4)b | 19 (0.2)ab | 306 (0.8)c | <0.001 |
P2 | 0.634 | 0.002 | 0.451 | 0.73 | |
Referral to a dietitian | |||||
males | 2346 (4.0)a | 6710 (11.7)b | 900 (7.2)c | 14,698 (28.4)d | <0.001 |
females | 4672 (8.6)a | 12,596 (21.1)b | 992 (12.0)c | 16,360 (40.5)d | <0.001 |
P2 | <0.001 | <0.001 | <0.001 | <0.001 | |
Referral to an endocrinologist | |||||
males | 2530 (4.4)a | 3795 (6.6)b | 292 (2.3)c | 4848 (9.4)d | <0.001 |
females | 3647 (6.7)a | 5735 (9.6)b | 273 (3.3)c | 5641 (14.0)d | <0.001 |
P2 | <0.001 | <0.001 | <0.001 | <0.001 | |
Additional BMI documentation | |||||
males | 32,768 (56.5)a | 45,602 (79.3)b | 5098 (40.6)c | 41,540 (80.1)d | <0.001 |
females | 30,977 (56.7)a | 47,632 (80.0)b | 3212 (38.8)c | 32,906 (81.4)d | <0.001 |
P2 | 0.585 | 0.003 | 0.009 | <0.001 | |
Prescription of metformin | |||||
males | 13 (0.0)a | 90 (0.2)b | 12 (0.1)b | 472 (0.9)c | <0.001 |
females | 41 (0.1)a | 214 (0.4)b | 11 (0.1)a | 711 (1.8)c | <0.001 |
P2 | <0.001 | <0.001 | 0.426 | <0.001 | |
Prescription of orlistat | |||||
males | 2 (0.0)a | 12 (0.0)b | 0a | 33 (0.1)c | <0.001 |
females | 5 (0.0)a | 42 (0.1)b | 0a | 63 (0.2)c | <0.001 |
P2 | 0.404 | <0.001 | <0.001 | ||
Prescription of GLP1 analogs | |||||
males | 3 (0.0)a | 132 (0.2)b | 3 (0.0)a | 818 (1.6)c | <0.001 |
females | 14 (0.0)a | 567 (1.0)b | 2 (0.0)a | 1427 (3.5)c | <0.001 |
P2 | 0.011 | <0.001 | 1 | <0.001 | |
1–2-year change in BMI-Z | |||||
males | (n = 12,589) −0.30 a (−0.73, 0.08) | (n = 21,614) −0.04 b (−0.45, 0.34) | (n = 1781) −0.33 c (−0.89, 0.02) | (n = 19,933) −0.01 d (−0.42, 0.16) | <0.001 |
females | (n = 11,830) -0.22 a (−0.58, 0.09) | (n = 22,413) −0.01 b (−0.35, 0.33) | (n = 1035) −0.30 c (−0.75, 0.02) | (n = 15,379) −0.06 d (−0.34, 0.17) | <0.001 |
P2 | <0.001 | <0.001 | 0.083 | <0.001 |